CD45RA+Foxp3+T cell (Population I) proportion within CD4+ cells was significantly smaller in MS than HD when comparing either all MS patients (p = 0.001) (Fig. 2B) or treatment naïve MS patients (p = 0.043) (Fig. 2E). This evidence concerns the gene CD4 and myeloid sarcoma.